![Jakob Hohenberger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jakob Hohenberger
Director of Finance/CFO at Celeris Therapeutics GmbH
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher Trummer | M | - |
Celeris Therapeutics GmbH
![]() Celeris Therapeutics GmbH Packaged SoftwareTechnology Services Celeris Therapeutics GmbH is a biotech company based in Graz, Austria. Celeris Therapeutics is developing novel approaches to biomolecular interaction determination and drug design, small organic molecules and degrader technologies against undruggable targets. The Austrian company was founded by Christopher Trummer and he has been the CEO since incorporation. | - |
Ronjon Nag | M | - |
Celeris Therapeutics GmbH
![]() Celeris Therapeutics GmbH Packaged SoftwareTechnology Services Celeris Therapeutics GmbH is a biotech company based in Graz, Austria. Celeris Therapeutics is developing novel approaches to biomolecular interaction determination and drug design, small organic molecules and degrader technologies against undruggable targets. The Austrian company was founded by Christopher Trummer and he has been the CEO since incorporation. | - |
Petr Šrámek | M | - |
Celeris Therapeutics GmbH
![]() Celeris Therapeutics GmbH Packaged SoftwareTechnology Services Celeris Therapeutics GmbH is a biotech company based in Graz, Austria. Celeris Therapeutics is developing novel approaches to biomolecular interaction determination and drug design, small organic molecules and degrader technologies against undruggable targets. The Austrian company was founded by Christopher Trummer and he has been the CEO since incorporation. | - |
Siham Ceballos | M | - |
Celeris Therapeutics GmbH
![]() Celeris Therapeutics GmbH Packaged SoftwareTechnology Services Celeris Therapeutics GmbH is a biotech company based in Graz, Austria. Celeris Therapeutics is developing novel approaches to biomolecular interaction determination and drug design, small organic molecules and degrader technologies against undruggable targets. The Austrian company was founded by Christopher Trummer and he has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Austria | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jakob Hohenberger
- Personal Network